Literature DB >> 15885627

A definition of Parkinson's disease.

Donald Calne1.   

Abstract

We are now entering a period when the process of unraveling the puzzles of 'Parkinson's Disease' has generated a mass of information that does not fit into our traditional concepts. Having split off 'Progressive Supranuclear Palsy' and 'Multiple System Atrophy', we are faced with the dilemma of what to do with the various forms of Parkinsonism caused by a number of different mutations, and how to interpret pathological heterogeneity. Faced with these new questions, it is time to reconsider how 'Parkinson's Disease' is to be defined.

Entities:  

Mesh：

Year:  2005        PMID： 15885627     DOI： 10.1016/j.parkreldis.2005.01.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


  8 in total

1.  Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.

Authors:  Jennifer E Tobin; Jing Cui; Jemma B Wilk; Jeanne C Latourelle; Jason M Laramie; Ann C McKee; Mark Guttman; Samer Karamohamed; Anita L DeStefano; Richard H Myers
Journal:  Brain Res       Date:  2007-01-08       Impact factor: 3.252

2.  Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease.

Authors:  Paula Scalzo; Arthur Kümmer; Thales Lage Bretas; Francisco Cardoso; Antônio Lúcio Teixeira
Journal:  J Neurol       Date:  2009-10-22       Impact factor: 4.849

3.  The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations.

Authors:  M Sharma; J C Mueller; A Zimprich; P Lichtner; A Hofer; P Leitner; S Maass; D Berg; A Dürr; V Bonifati; G De Michele; B Oostra; A Brice; N W Wood; B Muller-Myhsok; T Gasser
Journal:  J Med Genet       Date:  2006-01-27       Impact factor: 6.318

4.  Psychiatric disorders in primary focal dystonia and in Parkinson's disease.

Authors:  Fernando Mv Dias; Arthur Kummer; Flávia Cp Doyle; Estefânia Harsányi; Francisco Cardoso; Leonardo F Fontenelle; Antônio Lúcio Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-14       Impact factor: 2.570

5.  Argument-predicate distance as a filter for enhancing precision in extracting predications on the genetic etiology of disease.

Authors:  Marco Masseroli; Halil Kilicoglu; François-Michel Lang; Thomas C Rindflesch
Journal:  BMC Bioinformatics       Date:  2006-06-08       Impact factor: 3.169

6.  A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson's Disease in Isparta, Turkey.

Authors:  Nilufer Sahin-Calapoglu; Serpil Demirci; Mustafa Calapoglu; Baris Yasar
Journal:  Parkinsons Dis       Date:  2016-12-18

7.  Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.

Authors:  Yixian Huang; Wenwei Yun; Min Zhang; Weifeng Luo; Xianju Zhou
Journal:  J Int Med Res       Date:  2018-01-19       Impact factor: 1.671

8.  A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.

Authors:  Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; David J Brooks; Fabrizio Stocchi; Per Odin; Angelo Antonini; Richard G Brown; Richard J Brown; Pablo Martinez-Martin
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.